Tectonic Therapeutic (TECX) Interest & Investment Income (2017 - 2026)
Tectonic Therapeutic (TECX) reported Interest & Investment Income of $2.2 million for Q1 2026, down 10.76% year-over-year from $2.4 million in Q1 2025, and down 14.94% quarter-over-quarter from $2.6 million in Q4 2025.
Tectonic Therapeutic (TECX) Interest & Investment Income (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Interest & Investment Income data on file, last reported at $2.2 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $2.2 million, down 10.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.0 million (up 71.1% YoY), and the FY2025 annual result was $11.3 million, up 165.13% from the prior year.
- Interest & Investment Income eased to $2.2 million in Q1 2026 per TECX's latest filing, from $2.6 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $3.4 million in Q2 2025 and troughed at -$370000.0 in Q1 2022.
- A 5-year average of $1.1 million and a median of $256000.0 in 2024 frame the typical range for Interest & Investment Income.
- On a YoY basis, Interest & Investment Income climbed as much as 5450.0% in 2022 and fell as far as 3800.0% in 2022.
- A 5-year view of Interest & Investment Income shows it stood at $245000.0 in 2022, then tumbled by 45.71% to $133000.0 in 2023, then soared by 1204.51% to $1.7 million in 2024, then soared by 47.78% to $2.6 million in 2025, then dropped by 14.94% to $2.2 million in 2026.
- Business Quant data shows TECX's Interest & Investment Income at $2.2 million in Q1 2026, $2.6 million in Q4 2025, and $2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 2.56 Mn |
| Sep 30, 2025 | 2.90 Mn |
| Jun 30, 2025 | 3.39 Mn |
| Mar 31, 2025 | 2.44 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 318,000.00 |
| Mar 31, 2024 | 256,000.00 |
| Dec 31, 2023 | 133,000.00 |
| Sep 30, 2023 | 97,000.00 |
| Jun 30, 2023 | 224,000.00 |
| Mar 31, 2023 | 248,000.00 |
| Dec 31, 2022 | 245,000.00 |
| Sep 30, 2022 | 111,000.00 |
| Jun 30, 2022 | -285,000.00 |
| Mar 31, 2022 | -370,000.00 |
| Dec 31, 2021 | -245,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 9,000.00 |